Group One Trading
CTSO icon

Group One Trading’s Cytosorbents Corp CTSO Stock Holding History

Group One Trading’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,800
Closed -$5.26K – 7515
2023
Q3 		$5.26K Hold
2,800
– – ﹤0.01% 6677
2023
Q2 		$10.1K Sell
2,800
-1,400
-33% -$4.43K ﹤0.01% 6390
2023
Q1 		$14.2K Buy
+4,200
New +$12.6K ﹤0.01% 5747
2022
Q4 		– Sell
-2,900
Closed -$4K – 7364
2022
Q3 		$4K Hold
2,900
– – ﹤0.01% 6905
2022
Q2 		$6K Buy
2,900
+2,700
+1,350% +$6.2K ﹤0.01% 6987
2022
Q1 		$1K Sell
200
-500
-71% -$1.79K ﹤0.01% 7816
2021
Q4 		$3K Sell
700
-2,800
-80% -$15.7K ﹤0.01% 7765
2021
Q3 		$28K Sell
3,500
-50,800
-94% -$413K ﹤0.01% 6957
2021
Q2 		$410K Buy
54,300
+34,300
+172% +$289K ﹤0.01% 4447
2021
Q1 		$174K Buy
20,000
+13,800
+223% +$132K ﹤0.01% 5163
2020
Q4 		$49K Buy
6,200
+4,700
+313% +$39.3K ﹤0.01% 5016
2020
Q3 		$12K Sell
1,500
-32,300
-96% -$291K ﹤0.01% 5338
2020
Q2 		$335K Buy
33,800
+33,700
+33,700% +$309K ﹤0.01% 2948
2020
Q1 		$1K Buy
+100
New +$505 ﹤0.01% 5059
2019
Q2 		– Sell
-24,600
Closed -$186K – 5019
2019
Q1 		$186K Hold
24,600
– – ﹤0.01% 2758
2018
Q4 		$199K Buy
24,600
+5,900
+32% +$58.6K ﹤0.01% 2690
2018
Q3 		$241K Sell
18,700
-7,400
-28% -$92.8K ﹤0.01% 2883
2018
Q2 		$298K Sell
26,100
-500
-2% -$4.73K ﹤0.01% 2728
2018
Q1 		$188K Buy
26,600
+13,000
+96% +$98.2K ﹤0.01% 2839
2017
Q4 		$88K Buy
13,600
+7,400
+119% +$47.1K ﹤0.01% 3421
2017
Q3 		$38K Buy
6,200
+5,900
+1,967% +$30.1K ﹤0.01% 3771
2017
Q2 		$1K Buy
+300
New +$1.31K ﹤0.01% 4627
2016
Q4 		– Sell
-100
Closed -$1K – 4471
2016
Q3 		$1K Sell
100
-4,100
-98% -$21.3K ﹤0.01% 4423
2016
Q2 		$19K Sell
4,200
-36,900
-90% -$161K ﹤0.01% 3814
2016
Q1 		$161K Sell
41,100
-2,200
-5% -$9.55K ﹤0.01% 2473
2015
Q4 		$241K Buy
43,300
+23,400
+118% +$159K ﹤0.01% 2360
2015
Q3 		$126K Sell
19,900
-10,900
-35% -$72.7K ﹤0.01% 2875
2015
Q2 		$189K Buy
30,800
+26,400
+600% +$180K ﹤0.01% 2558
2015
Q1 		$58K Buy
+4,400
New +$45.3K ﹤0.01% 3278

Other funds holding CTSO

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's CTSO Position: Q3 2023 in Review

Group One Trading sold out of Cytosorbents Corp (CTSO) in Q3 2023, closing a stake of 4,263 shares — an estimated $12.2K sold.

Group One Trading first reported a position in CTSO in Q3 2016 and held it in 18 quarters. The position peaked at $117K in Q2 2018. 53 funds tracked by Wall St. Rank hold CTSO as of Q3 2023.

  • Group One Trading reported no remaining Cytosorbents Corp position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 4,263 Cytosorbents Corp shares in Q3 2023, an estimated $12.2K.
  • Group One Trading first reported a position in Cytosorbents Corp in Q3 2016 and held it in 18 quarters.
  • Group One Trading's Cytosorbents Corp position peaked at $117K in Q2 2018.
  • 53 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.